# OnCo record nct01310894 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01310894/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01310894", "NCT01310894" ;
  schema:name "Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance"@en ;
  schema:alternateName "PCM301"@en, "CLIN1001 PCM301"@en, "TOOKAD Soluble phase 3"@en ;
  schema:description "A phase 3 trial of Padeliporfin in Prostate cancer, run by Steba Biotech S.A., completed."@en ;
  schema:url <https://onco.cc/trials/nct01310894/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01310894>, <https://doi.org/10.1016/S1470-2045(16)30661-1>, <https://www.nice.org.uk/guidance/ta546> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2011-02" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/> ;
  onco:drugs <https://onco.cc/drugs/padeliporfin/> ;
  onco:companies <https://onco.cc/companies/steba-biotech/> ;
  onco:terms <https://onco.cc/terms/prostate-focal-therapy/> ;
  onco:trials <https://onco.cc/trials/protect/> .